文献速递脑血管病

DAWN试验:手术期与技术因素及患者特征对晚期取栓再通与结局的影响

Impact of Periprocedural and Technical Factors and Patient Characteristics on Revascularization and Outcome in the DAWN Trial.
PubMed 文献 · Stroke · 2019-11-20

DAWN试验纳入症状出现6至24小时、存在临床-梗死体积不匹配的前循环大血管闭塞患者,分析107例接受机械取栓者的手术期与技术因素。结果显示,需要≥3次取栓 pass 的患者显著再通和3个月功能独立均更差,基线NIHSS>17亦与不良结局相关。

要点

  • DAWN试验中,≥3次取栓pass与显著再通降低独立相关。
  • ≥3次取栓pass和基线NIHSS>17与3个月功能独立降低独立相关。
  • 全麻和≥3次支架取栓pass在单变量中与显著再通负相关。

核心结论

  • 在DAWN试验中,需要≥3次取栓pass的患者显著再通和3个月良好功能结局均降低。

研究设计与样本

  • DAWN试验为随机对照试验,纳入症状出现6至24小时、前循环大血管闭塞且临床-梗死体积不匹配的患者。
  • 本分析纳入DAWN介入组中107例接受机械取栓的患者。

主要发现

  • 107例接受机械取栓患者中,90例(84%)达到显著再通,52例(49%)3个月mRS评分为0至2分。
  • 单变量分析中,全麻与显著再通负相关(OR 0.27;P=0.042),≥3次支架取栓pass与显著再通负相关(OR 0.17;P=0.002)。
  • 多变量分析中,仅≥3次pass与未再通独立相关(OR 0.17;P=0.002)。
  • 单变量分析中,≥3次pass(OR 0.24;P=0.003)和基线NIHSS>17(OR 0.19;P<0.001)与3个月功能独立负相关。
  • 多变量分析中,≥3次pass(OR 0.24;P=0.003)和基线NIHSS>17(OR 0.19;P<0.001)仍与3个月良好结局负相关。

临床怎么用

  • 对于晚期时间窗取栓患者,应关注取栓pass次数,≥3次pass提示再通和功能结局可能更差。
  • 基线NIHSS>17的晚期时间窗取栓患者,3个月功能独立可能性更低。

局限性

  • 原文未报告本分析的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Because of unique attributes of mechanical thrombectomy performed between 6 and 24 hours after symptom onset in acute ischemic stroke patients, it is not known if predictors of angiographic recanalization and favorable outcome in patients treated with thrombectomy in the late (6-24 hour) time window are similar to those treated in the early time window. Methods- We analyzed data from the DAWN trial (DWI or CTP Assessment With Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention With Trevo) which enrolled patients with symptom onset 6 to 24hours after last known well and occlusion of the intracranial internal carotid artery or proximal middle cerebral artery with a mismatch between severity of clinical deficit and infarct core volume as identified by computed tomography-perfusion or diffusion magnetic resonance imaging. We evaluated the effect of tandem occlusions, periprocedural heparin use, procedural speed (from puncture to procedure completion), general anesthesia, balloon-guide catheters, thrombectomy device size, and number of passes on substantial reperfusion (modified Thrombolysis in Cerebral Infarction 2b/3) and on likelihood of obtaining a modified Rankin Scale at 3 months indicating functional independence. Results- Of 107 patients who underwent MT in the interventional arm of DAWN, substantial reperfusion and modified Rankin Scale score 0 to 2 at 3 months was seen in 90 (84%) and 52 (49%), respectively. In univariate analysis, general anesthesia (odds ratio [OR] 0.27; P=0.042) and ≥3 passes with stent retriever (OR, 0.17; P=0.002) were inversely associated with substantial reperfusion. In multivariate analyses, only ≥3 passes were associated with lack of revascularization (OR, 0.17; P=0.002). in univariate analysis ≥3 passes (OR, 0.24; P =0.003) and baseline National Institutes of Health Stroke Scale score >17 (OR, 0.19; P<0.001) were inversely associated with functional independence at 3 months. In multivariate analyses, ≥3 passes (OR, 0.24; P=0.003) and National Institutes of Health Stroke Scale score >17 (OR, 0.19; P<0.001) remained inversely associated with favorable outcome at 3 months. Conclusions- Patients requiring ≥3 thrombectomy passes had reduced substantial reperfusion and favorable outcome at 3 months in DAWN. Whether or not additional thrombectomy techniques beyond ≥3 thrombectomy passes with the Trevo stent retriever are beneficial for patient outcomes in this patient population remains to be clarified by future studies. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT02142283.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tekle WG, Hassan AE, Jadhav AP, et al. Impact of Periprocedural and Technical Factors and Patient Characteristics on Revascularization and Outcome in the DAWN Trial. Stroke. 2019. PMID: 31744425. doi:10.1161/STROKEAHA.119.026437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。